Search results
Bayer's (BAYRY) Elinzanetant Meets Goals in Third Phase III Study
Zacks via Yahoo Finance· 1 month agoBayer's (BAYRY) pipeline candidate, elinzanetant, achieves primary and secondary goals in late-stage...
Bayer (BAYRY) Earnings & Revenues Surpass Estimates in Q1
Zacks via Yahoo Finance· 2 years agoBayer AG BAYRY reported first-quarter 2022 core earnings of 99 cents per American Depositary Receipt...
Regeneron (REGN) Q1 Earnings Beat, COVID Antibody Sales Affected
Zacks via Yahoo Finance· 2 years agoRegeneron Pharmaceuticals, Inc. REGN posted better-than-expected first-quarter 2022 results, beating...
Regeneron (REGN) Q4 Earnings & Sales Beat, Eylea Sales Decline
Zacks via Yahoo Finance· 1 year agoRegeneron Pharmaceuticals, Inc. REGN delivered better-than-expected fourth-quarter 2022 results even...
25 Biggest Pharmaceutical Companies in the World A Year Ago
Insider Monkey via Yahoo Finance· 2 years agoIn this article we listed the 25 biggest pharmaceutical companies in the world a year ago and then...
Top 20 Most Profitable Pharmaceutical Companies In The World
Insider Monkey via Yahoo Finance· 10 months agoIn this article, we will be covering the top 20 most profitable pharmaceutical companies in the...
12 Most Profitable Pharmaceutical Stocks Now
Insider Monkey via Yahoo Finance· 1 year agoIn this piece, we will take a look at 12 most profitable pharmaceutical stocks now. For more stocks, head on over to 5 Most Profitable Pharmaceutical...
30 Largest Pharmaceutical Companies in the World
Insider Monkey via Yahoo Finance· 4 months agoIn this article, we will be taking a look at the 30 largest pharmaceutical companies in the world. To skip our detailed analysis, you can go directly to...
Lantheus Holdings Is Charting a Path to Sustainable Growth and Value
GuruFocus.com via Yahoo Finance· 4 months agoLantheus Holdings Inc. (NASDAQ:LNTH) is one of the leading companies in the global medical imaging...
AstraZeneca's (AZN) Imfinzi/Imjudo Combo Gets Another FDA Nod
Zacks via Yahoo Finance· 1 year agoAstraZeneca AZN announced that the FDA approveda dual immunotherapy regimen consisting of PD-L1...